Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway.
Nat Commun. 2021 Mar 19;12(1):1717. doi: 10.1038/s41467-021-22033-2.
Nat Commun. 2021.
PMID: 33741967
Free PMC article.